Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
PHASE2CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
November 30, 2013
Primary Completion Date
July 31, 2016
Study Completion Date
August 5, 2016
Conditions
Diabetes Mellitus Type 1
Interventions
DRUG
Sitagliptin
DRUG
Exercise
Trial Locations (1)
4031
University Hospital Basel, Basel
All Listed Sponsors
lead
University Hospital, Basel, Switzerland
OTHER
NCT02127047 - Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter